WEDNESDAY, Nov. 10 (HealthDay News) -- In an effort to improve
screening for dementia and mild cognitive impairment among seniors,
a team of researchers has developed a test designed to spot
problems in thinking, learning and memory skills in under three
Dubbed "The Sweet 16" for its 16-point scale, the test appears
to quickly uncover telltale signs of dementia through a cognition
ranking system that grades mental skills from a low of zero up to a
high of 16.
The study team cautions that the test requires further scrutiny
to establish its reliability, particularly as it compares to a
well-established measure of cognitive impairment -- the Mini-Mental
State Examination (MMSE) -- now currently in widespread use.
But if early positive results hold up, its creators hope that
this new diagnostic tool will eventually boost the ability of
physicians to identify the onset of dementia among older
"For many older adults, cognitive impairment contributes to loss of independence, decreased quality of life and increased health-care costs," the study authors, led by Dr. Tamara G. Fong, of Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, said in a news release.
"While the public health impact of cognitive impairment is clear, this condition is often under-recognized," the researchers added. "A simple, rapid cognitive assessment instrument is therefore a valuable tool for use in both clinical and research settings."
Fong and her team outline their new screening method online in
Archives of Internal Medicine.
The authors note that currently an estimated 3.4 million
American seniors are diagnosed with dementia, while another 5.4
million are suffering from mild forms of cognitive impairment.
Fong and her team also point out that efforts to screen for
either condition are imperfect under the MMSE, the current gold
standard for dementia testing. That test has copyright controls
that limit its availability, and the results it provides may be
compromised by patients differing educational backgrounds, they
To fashion an alternative screening mechanism, the authors first
reviewed data collected from 774 patients who had been screened
with the MMSE. Most of the results of that screening were further
confirmed by two additional dementia/cognitive decline ranking
Based on these analyses, the authors developed a series of
questions focused on recall skills, verbal memory performance, and
orientation issues such as the ability to identify a person, place,
time and/or situation.
The final test was designed to be simple and fast. The screening
involves no pencil or paper and can be completed in an average of
When tried out, a score of 14 or less was found to detect 80
percent of cognitive impairment cases, compared with the 64 percent
success score logged by the MMSE.
However, the MMSE outperformed the Sweet 16 with respect to
correctly identifying patients with no cognitive impairment: 86
percent success vs. 70 percent, respectively.
Nevertheless, when compared with clinician assessments, Sweet 16
scores of 14 or less occurred in 99 percent of the patients
diagnosed with cognitive impairment. Scores of 14 or less also
occurred in 28 percent of people who were not diagnosed with
cognitive impairment, suggesting a potentially high rate of false
Dr. Gary J. Kennedy, director of geriatric psychiatry at
Montefiore Medical Center in New York City, said that while better
cognitive testing is needed, the jury is still out on whether or
not the current innovation will fit the bill.
"Do we need something better than the MMSE?," he asked. "Absolutely. It's cumbersome to use. You need pencils and paper and props to administer it. And there are also a lot of difficulties with how to score it."
"And I would say that reading this description of the 'Sweet 16,' it sounds like it's much more easily administrated," Kennedy observed. "But still, I'm not convinced this is the answer to the problem. Because diagnosing cognitive impairment is not the same as diagnosing diabetes. It's much more complicated than that. People's cognition varies with life experience. It's not like simply testing for blood sugar levels. There isn't a single diagnostic marker."
For more on seniors and dementia, visit the
U.S. National Institutes of Health.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.